← Back to Search

ESKD with Burnt-out Diabetes for Kidney Failure

N/A

Waitlist Available

Led By Guillermo Umpierrez, MD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to day 10

Awards & highlights

Study Summary

This trial will test if CGM is better than HbA1c for monitoring glucose in people with kidney failure and diabetes on dialysis.

Eligible Conditions

Kidney Failure

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to day 10

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to day 10

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to day 10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Duration of Hyperglycemia (Blood Glucose >180 mg/dL)

Duration of Hyperglycemia (Blood Glucose >250 mg/dL)

Hypoglycemia Event Rate

+9 more

Secondary outcome measures

Glycemic Variability Calculated by Mean Amplitude of Glycemic Excursions (MAGE)

Mean Daily Blood Glucose Concentration

Trial Design

2Treatment groups

Experimental Treatment

Group I: ESKD without DiabetesExperimental Treatment1 Intervention

Non-diabetic participants with ESKD wearing a CGM for 10 days.

Group II: ESKD with Burnt-out DiabetesExperimental Treatment1 Intervention

Participants with ESKD and burnt-out diabetes wearing a CGM for 10 days.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Continuous glucose monitoring (CGM)

2016

Completed Phase 4

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,636 Previous Clinical Trials

2,560,533 Total Patients Enrolled

3 Trials studying Kidney Failure

1,551 Patients Enrolled for Kidney Failure

Guillermo Umpierrez, MDPrincipal InvestigatorEmory University

33 Previous Clinical Trials

11,481 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the most extensive patient cohort involved in this investigation?

"Affirmative. According to information on clinicaltrials.gov, this investigation is actively searching for participants and was first uploaded on August 10th 2022. Recently updated as of February 14th 2023, the trial requires 40 patients from 4 distinct sites."

Answered by AI

Are individuals able to participate in this experimental research at the present time?

"Affirmative, this clinical trial is currently recruiting - as per data published on clinicaltrials.gov. This research project was originally uploaded on August 10th 2022 and the latest updates were added on February 14th 2023. The study requires 40 participants from 4 medical centres to be enrolled in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes

Guillermo Umpierrez 2022. "Continuous Glucose Monitoring in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05741489.